Recombinant Human ELFN2 Protein, CF

Name: Recombinant Human ELFN2 Protein, CF
Brand: R&D Systems
SKU: 9329-EF
Price: 453 USD

R&D Systems, Inc. a Bio-Techne Brand

Catalog # 9329-EF

Product Datasheet / COA / SDS

Catalog #

Availability

Size / Price

Qty

Setting the standard in quality research reagents

Key Product Details

Source:	HEK293
Accession #:	Q5R3F8
Applications:	Bioactivity

View Full Technical Details for Recombinant Human ELFN2 Protein, CF

Product Specifications for Recombinant Human ELFN2 Protein, CF

Source	Human embryonic kidney cell, HEK293-derived human ELFN2 protein Asp23-Tyr397, with a C-terminal 6-His tag
Purity	>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin level	<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal sequence Analysis	Asp23
Predicted Molecular Mass	43 kDa
SDS-PAGE	71-94 kDa, non-reducing conditions
Activity	Measured by its ability to inhibit neurite outgrowth of E16-E18 rat embryonic cortical neurons on a Laminin alpha 4 coated plate. Able to significantly inhibit neurite outgrowth when immobilized as a 3 μL droplet containing 300 ng of protein.

Formulation, Preparation and Storage

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

9329-EF

Formulation	Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution	Reconstitute at 500 μg/mL in PBS. Reconstitution Buffer Available: Size / Price Qty Loading... RB01:
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Background: ELFN2

ELFN2 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2), also known as protein phosphatase 1 regulatory subunit 29, is a member of the extracellular Leucine-Rich Repeat superfamily (1). Expressed mainly in the nervous system, ELFN2 is a transmembrane protein that inhibits the activity of protein phosphatase 1 (PP1) complexes (2). Mature human ELFN2 consists of a 375 aa extracellular domain (ECD), a 21 aa transmembrane segment and a 402 aa cytoplasmic tail. The ECD includes one fibronectin type-III domain, five leucine-rich repeats (LRR) and one LRR C-terminal (LRRCT) domain. Human ELFN2 shares 98% aa sequence identity with mouse and rat ELFN2. Expression of ELFN2 is quite restricted to the nervous system in which it is broadly expressed in the cortex in presumed glutamatergic neurons, in hippocampal pyramidal and granule cells, and in the striatum. These patterns are maintained in adults. Given the functions and discrete patterns of many known LRR family proteins it has been proposed that ELFN2 could provide the requisite specificity of cellular interactions to mediate a large number of selective connectivity decisions involved in neurite outgrowth, axon guidance, fasciculation, and synapse formation (1). Mutations of ELFN2 have been reported in pancreatic cancer radiation resistance (3) and stress fracture (4).

Item	Value
References	Dolan J. et al. (2007) BMC Genomics 8:320. Hendrickx, A. et al. (2009) Chem. Biol. 16:365. Friedman E. et al. (2014) Genet Res (Camb) 96:e004. Souchek L.L. et al. (2014) British Journal of Cancer 111:1139.
Long Name	Extracellular Leucine-Rich Repeat And Fibronectin Type III Domain Containing 2
Entrez Gene IDs	114794 (Human); 207393 (Mouse)
Alternate Names	ELFN2, KIAA1904, LRRC62, PPP1R29, dJ63G5.3, dJ63G5.3 (putative Leucine rich protein), extracellular leucine-rich repeat and fibronectin type III containing 2, extracellular leucine-rich repeat and fibronectin type III domain containing 2, extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2, leucine rich repeat containing 62, leucine-rich repeat and fibronectin type-III domain-containing protein 6, leucine-rich repeat-containing protein 62, protein phosphatase 1, regulatory subunit 29

Citations for Recombinant Human ELFN2 Protein, CF

Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

Recombinant Human ELFN2 Protein, CF

R&D Systems, Inc. a Bio-Techne Brand

Key Product Details

Customers also Viewed

Customers also Purchased

Product Specifications for Recombinant Human ELFN2 Protein, CF

Formulation, Preparation and Storage

Carrier Free

Reconstitution Calculator

Background: ELFN2

Citations for Recombinant Human ELFN2 Protein, CF

Product Documents for Recombinant Human ELFN2 Protein, CF

Product Datasheets

COA

Certificate of Analysis

SDS

Bio-Techne Brands

Stay Connected